These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32236941)

  • 1. Effects of simulated sample sizes on the mortality effect estimates in three randomized intensive care unit trials.
    Kofoed A; Perner A; Marker S; Haase N; Holst LB; Møller MH
    Acta Anaesthesiol Scand; 2020 Aug; 64(7):976-981. PubMed ID: 32236941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of simulated sample sizes on mortality estimates-Protocol for a study in 3 randomised ICU trials.
    Kofoed A; Perner A; Marker S; Haase N; Holst LB; Møller MH
    Acta Anaesthesiol Scand; 2019 Sep; 63(8):1098-1101. PubMed ID: 31032881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pantoprazole in ICU patients at risk for gastrointestinal bleeding-1-year mortality in the SUP-ICU trial.
    Marker S; Krag M; Perner A; Wetterslev J; Lange T; Wise MP; Borthwick M; Bendel S; Keus F; Guttormsen AB; Schefold JC; Rasmussen BS; Elkmann T; Bestle M; Arenkiel B; Laake JH; Kamper MK; Lång M; Pawlowicz-Dworzanska MB; Karlsson S; Liisanantti J; Dey N; Knudsen H; Granholm A; Møller MH;
    Acta Anaesthesiol Scand; 2019 Oct; 63(9):1184-1190. PubMed ID: 31282567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial.
    Perner A; Haase N; Wetterslev J; Aneman A; Tenhunen J; Guttormsen AB; Klemenzson G; Pott F; Bødker KD; Bådstøløkken PM; Bendtsen A; Søe-Jensen P; Tousi H; Bestle M; Pawlowicz M; Winding R; Bülow HH; Kancir C; Steensen M; Nielsen J; Fogh B; Madsen KR; Larsen NH; Carlsson M; Wiis J; Petersen JA; Iversen S; Schøidt O; Leivdal S; Berezowicz P; Pettilä V; Ruokonen E; Klepstad P; Karlsson S; Kaukonen M; Rutanen J; Karason S; Kjældgaard AL; Holst LB; Wernerman J;
    Trials; 2011 Jan; 12():24. PubMed ID: 21269526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Prophylactic Pantoprazole in Adult Intensive Care Unit Patients Receiving Dialysis: Results of a Randomized Trial.
    Schefold JC; Krag M; Marker S; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Keus F; Guttormsen AB; Lange T; Møller MH;
    Am J Nephrol; 2019; 50(4):312-319. PubMed ID: 31480045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials.
    He B; Xu B; Xu X; Li L; Ren R; Chen Z; Xiao J; Wang Y; Xu B
    Crit Care; 2015 Mar; 19(1):92. PubMed ID: 25886952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Hospital and Patient Characteristics with Fluid Resuscitation Volumes in Patients with Severe Sepsis: Post Hoc Analyses of Data from a Multicentre Randomised Clinical Trial.
    Hjortrup PB; Haase N; Wetterslev J; Perner A
    PLoS One; 2016; 11(5):e0155767. PubMed ID: 27196104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.
    Holst LB
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyethyl starch versus saline for resuscitation of patients in intensive care: long-term outcomes and cost-effectiveness analysis of a cohort from CHEST.
    Taylor C; Thompson K; Finfer S; Higgins A; Jan S; Li Q; Liu B; Myburgh J;
    Lancet Respir Med; 2016 Oct; 4(10):818-825. PubMed ID: 27324967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute kidney injury with hydroxyethyl starch 130/0.42 in severe sepsis.
    Müller RB; Haase N; Lange T; Wetterslev J; Perner A
    Acta Anaesthesiol Scand; 2015 Mar; 59(3):329-36. PubMed ID: 25524831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post-hoc analyses of a randomised trial.
    Müller RG; Haase N; Wetterslev J; Perner A
    Intensive Care Med; 2013 Nov; 39(11):1963-71. PubMed ID: 24037226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preemptive volume therapy to prevent hemodynamic changes caused by the beach chair position: hydroxyethyl starch 130/0.4 versus Ringer's acetate-a controlled randomized trial.
    Frey K; Rehm M; Chappell D; Eisenlohr J; Crispin A; Saller T; Groene P; Ockert B; Hofmann-Kiefer KF
    J Shoulder Elbow Surg; 2018 Dec; 27(12):2129-2138. PubMed ID: 30322751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hydroxyethyl starch 130/0.42 vs. Ringer's acetate on cytokine levels in severe sepsis.
    Anthon CT; Müller RB; Haase N; Hjortrup PB; Møller K; Lange T; Wetterslev J; Perner A
    Acta Anaesthesiol Scand; 2017 Sep; 61(8):904-913. PubMed ID: 28653377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The design of the VISEP trial. Critical appraisal].
    Zander R; Boldt J; Engelmann L; Mertzlufft F; Sirtl C; Stuttmann R
    Anaesthesist; 2007 Jan; 56(1):71-7. PubMed ID: 17192828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pantoprazole prophylaxis in ICU patients with high severity of disease: a post hoc analysis of the placebo-controlled SUP-ICU trial.
    Marker S; Perner A; Wetterslev J; Krag M; Lange T; Wise MP; Borthwick M; Bendel S; Keus F; Guttormsen AB; Schefold JC; Møller MH;
    Intensive Care Med; 2019 May; 45(5):609-618. PubMed ID: 30863936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of pantoprazole vs. placebo on 1-year outcomes, resource use and employment status in ICU patients at risk for gastrointestinal bleeding: a secondary analysis of the SUP-ICU trial.
    Halling CMB; Møller MH; Marker S; Krag M; Kjellberg J; Perner A; Gyrd-Hansen D
    Intensive Care Med; 2022 Apr; 48(4):426-434. PubMed ID: 35122105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyethyl starch in sepsis.
    Haase NR
    Dan Med J; 2014 Jan; 61(1):B4764. PubMed ID: 24393593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of hydroxyethyl starch on exogenous coagulation and active protein C in patients with septic shock].
    Lyu J; Li T; Liu F; An Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jan; 27(1):28-32. PubMed ID: 25591433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress ulcer prophylaxis in the intensive care unit trial: detailed statistical analysis plan.
    Krag M; Perner A; Wetterslev J; Lange T; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Meyhoff TS; Marker S; Møller MH
    Acta Anaesthesiol Scand; 2017 Aug; 61(7):859-868. PubMed ID: 28608496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU.
    Krag M; Marker S; Perner A; Wetterslev J; Wise MP; Schefold JC; Keus F; Guttormsen AB; Bendel S; Borthwick M; Lange T; Rasmussen BS; Siegemund M; Bundgaard H; Elkmann T; Jensen JV; Nielsen RD; Liboriussen L; Bestle MH; Elkjær JM; Palmqvist DF; Bäcklund M; Laake JH; Bådstøløkken PM; Grönlund J; Breum O; Walli A; Winding R; Iversen S; Jarnvig IL; White JO; Brand B; Madsen MB; Quist L; Thornberg KJ; Møller A; Wiis J; Granholm A; Anthon CT; Meyhoff TS; Hjortrup PB; Aagaard SR; Andreasen JB; Sørensen CA; Haure P; Hauge J; Hollinger A; Scheuzger J; Tuchscherer D; Vuilliomenet T; Takala J; Jakob SM; Vang ML; Pælestik KB; Andersen KLD; van der Horst ICC; Dieperink W; Fjølner J; Kjer CKW; Sølling C; Sølling CG; Karttunen J; Morgan MPG; Sjøbø B; Engstrøm J; Agerholm-Larsen B; Møller MH;
    N Engl J Med; 2018 Dec; 379(23):2199-2208. PubMed ID: 30354950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.